Joo-Ho Chung

Dr. Joo-Ho Chung

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009 in The Korean Journal of Physiology & Pharmacology
Verified
Journal Article
Open access
PDF file
HKHak-Jae Kim
Hak-Jae Kim
JSJeong Yoon Song
Jeong Yoon Song
HPHae Jeong Park
Hae Jeong Park
HPHyun-Kyung Park
Hyun-Kyung Park
DYDong Hwan Yun
Dong Hwan Yun
JCJoo-Ho Chung
Joo-Ho Chung
Kim HJ, et al. Korean J Physiol Pharmacol. 2009 Aug;13(4):281-285. http://dx.doi.org/10.4196/kjpp.2009.13.4.281

19 July 2004 in Arthritis Research & Therapy
Verified
Journal Article
Open access
SJSheng-Yu Jin
Sheng-Yu Jin
SHSeung-Jae Hong
Seung-Jae Hong
HYHyung In Yang
Hyung In Yang
SPSang-Do Park
Sang-Do Park
MYMyung-Chul Yoo
Myung-Chul Yoo
JCJoo-Ho Chung
Joo-Ho Chung
Estrogen and estrogen receptors (ERs) are known to play important roles in the pathophysiology of osteoarthritis (OA). To investigate ER-alpha gene polymorphisms for its associations with primary knee OA, we conducted a case-control association study in patients with primary knee OA (n = 151) and healthy individuals (n = 397) in the Korean population. Haplotyping analysis was used to determine the relationship between three polymorphisms in the ER-alpha gene (intron 1 T/C, intron 1 A/G and exon 8 G/A) and primary knee OA. Genotypes of the ER-alpha gene polymorphism were determined by PCR followed by restriction enzyme digestion (PvuII for intron 1 T/C, XbaI for intron 1 A/G, and BtgI for exon 8 G/A polymorphism). There was no significant difference between primary knee OA patients and healthy control individuals in the distribution of any of the genotypes evaluated. However, we found that the allele frequency for the exon 8 G/A BtgI polymorphism (codon 594) was significantly different between primary knee OA patients and control individuals (odds ratio = 1.38, 95% confidence interval = 1.01-1.88; P = 0.044). In haplotype frequency estimation analysis, there was a significant difference between primary knee OA patients and control individuals (degrees of freedom = 7, chi2 = 21.48; P = 0.003). Although the number OA patients studied is small, the present study shows that ER-alpha gene haplotype may be associated with primary knee OA, and genetic variations in the ER-alpha gene may be involved in OA.

28 April 2011 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
HPHae Jeong Park
Hae Jeong Park
JPJin Kyung Park
Jin Kyung Park
SKSu Kang Kim
Su Kang Kim
ACAh-Rang Cho
Ah-Rang Cho
JKJong Woo Kim
Jong Woo Kim
JCJoo-Ho Chung
Joo-Ho Chung

1 October 2011 in Archives of Oral Biology
Verified
Journal Article
Closed access
SKSang Wook Kang
Sang Wook Kang
HPH.J. Park
H.J. Park
JBJu Yeon Ban
Ju Yeon Ban
JCJoo-Ho Chung
Joo-Ho Chung
GCG.S. Chun
G.S. Chun
JCJ.O. Cho
J.O. Cho

31 August 2005 in Behavioral and Brain Functions
Verified
Journal Article
Open access
PDF file
HLHee Jae Lee
Hee Jae Lee
JSJi Young Song
Ji Young Song
JKJong Woo Kim
Jong Woo Kim
SJSheng-Yu Jin
Sheng-Yu Jin
MHMi Suk Hong
Mi Suk Hong
YFYasuyuki Fukumaki
Yasuyuki Fukumaki
Background: The occurrence of aberrant functional connectivity in the neuronal circuit is one of the integrative theories of the etiology of schizophrenia. Previous studies have reported that the protein and mRNA levels of the synapsin 2 (SYN2) and complexin 2 (CPLX2) genes were decreased in patients with schizophrenia. Synapsin 2 and complexin 2 are involved in synaptogenesis and the modulation of neurotransmitter release. This report presents a study of the association of polymorphisms ofSYN2andCPLX2with schizophrenia in the Korean population.Methods: Six single nucleotide polymorphisms (SNPs) and one 5-bp insertion/deletion inSYN2and five SNPs inCPLX2were genotyped in 154 Korean patients with schizophrenia and 133 control patients using direct sequencing or restriction fragment length polymorphism analysis. An intermarker linkage disequilibrium map was constructed for each gene.Results: Although there was no significant difference in the genotypic distributions and allelic frequencies of eitherSYN2orCPLX2polymorphisms between the schizophrenia and control groups, the two-way haplotype analyses revealed significant associations with the disease (P< 0.05 after Bonferroni correction). The three-way haplotype analyses also revealed a significant association ofSYN2with schizophrenia (P< 0.001 after Bonferroni correction).Conclusion: These results suggest that bothSYN2andCPLX2may confer susceptibility to schizophrenia in the Korean population.

14 September 2007 in Epilepsia
Verified
Journal Article
Open access
PDF file
HPHae Jeong Park
Hae Jeong Park
HKHak-Jae Kim
Hak-Jae Kim
HPHi Joon Park
Hi Joon Park
JRJehyun Ra
Jehyun Ra
LZLong Tai Zheng
Long Tai Zheng
JCJoo-Ho Chung
Joo-Ho Chung
Summary: The protective effect of topiramate (TPM) on seizure‐induced neuronal injury is well known; however, its molecular basis has yet to be elucidated. We investigated the effect and signaling mediators of TPM on seizure‐induced hippocampal cell death in kainic acid (KA)‐treated ICR mice. KA‐induced hippocampal cell death was identified by terminal deoxynucleotidyl transferase–mediated dUTP nick end labeling. Immunoreactivity (IR) of p‐Erk, p‐Jnk, p‐P38, and caspase‐3, and caspase‐3 activity were observed in the hippocampal region 3 h after KA (0.1 μg/5 μL, i.c.v.) administration, and/or TPM (100 mg/kg, i.p.) pretreatment. TPM attenuated seizure‐induced neuronal cell death and reduced KA‐induced p‐Erk IR in the CA3 region of the hippocampus, but did not affect p‐Jnk and p‐P38. In addition, TPM reduced caspase‐3 IR and activation by KA. KA‐induced seizures were also suppressed by TPM pretreatment. TPM inhibits seizures, and decreases Erk phosphorylation and caspase‐3 activation by KA, thereby contributing to protection from neuronal injury.